CRIS Current Research Information System

MARZOCCHI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.638
AS - Asia 5.142
EU - Europa 4.744
AF - Africa 438
SA - Sud America 285
Continente sconosciuto - Info sul continente non disponibili 281
OC - Oceania 13
Totale 17.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.529
VN - Vietnam 1.587
SG - Singapore 1.291
CN - Cina 1.241
GB - Regno Unito 1.052
DE - Germania 915
IT - Italia 512
SE - Svezia 473
NL - Olanda 442
HK - Hong Kong 330
UA - Ucraina 291
FR - Francia 288
IN - India 234
RU - Federazione Russa 215
BR - Brasile 194
IE - Irlanda 179
JP - Giappone 97
NG - Nigeria 93
TG - Togo 86
EE - Estonia 84
SC - Seychelles 83
CI - Costa d'Avorio 77
ZA - Sudafrica 77
BG - Bulgaria 71
FI - Finlandia 70
KR - Corea 65
CA - Canada 60
CH - Svizzera 56
JO - Giordania 42
PH - Filippine 40
BD - Bangladesh 35
AR - Argentina 32
IR - Iran 28
TH - Thailandia 27
BE - Belgio 24
MX - Messico 22
IQ - Iraq 18
CO - Colombia 16
TR - Turchia 16
EC - Ecuador 14
PL - Polonia 14
TW - Taiwan 13
SA - Arabia Saudita 12
AU - Australia 11
ES - Italia 11
ID - Indonesia 11
AT - Austria 9
PK - Pakistan 9
CL - Cile 8
UZ - Uzbekistan 8
EG - Egitto 7
LT - Lituania 6
MY - Malesia 6
PY - Paraguay 6
GR - Grecia 5
HN - Honduras 5
OM - Oman 5
PE - Perù 5
RO - Romania 5
JM - Giamaica 4
AM - Armenia 3
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HR - Croazia 3
LB - Libano 3
MN - Mongolia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
MA - Marocco 2
MM - Myanmar 2
MQ - Martinica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
HT - Haiti 1
IS - Islanda 1
KZ - Kazakistan 1
Totale 17.250
Salva come PNG Salva come JPEG
Città #
Southend 909
Singapore 901
Ashburn 648
Fairfield 545
Chandler 467
Frankfurt am Main 372
San Jose 365
Eygelshoven 337
Hong Kong 315
Santa Clara 299
Ho Chi Minh City 265
Woodbridge 258
Seattle 256
Hanoi 254
Wilmington 252
Houston 250
Dong Ket 217
Ann Arbor 216
Princeton 209
Jacksonville 201
Cambridge 199
Council Bluffs 191
Beijing 181
Dublin 176
Boardman 139
Hefei 126
Abeokuta 92
Padova 92
Westminster 92
New York 91
Lauterbourg 89
Nanjing 89
Tokyo 87
Lomé 86
Abidjan 76
Los Angeles 74
Berlin 73
Bologna 70
Turin 70
Sofia 68
Bremen 66
Helsinki 52
Da Nang 51
Bern 48
Buffalo 47
Chicago 44
Jinan 44
Amman 42
São Paulo 41
Milan 40
Nanchang 40
Seoul 40
Saint Petersburg 39
Dallas 36
Changsha 35
Dearborn 35
San Diego 35
Guangzhou 34
Haiphong 34
Shenyang 34
Mülheim 33
Medford 32
Shanghai 32
Redondo Beach 31
Hebei 30
Munich 30
Brussels 23
Mahé 23
The Dalles 23
Falkenstein 22
Paris 22
Phoenix 22
Tianjin 21
Olalla 20
Jiaxing 19
Zhengzhou 19
Mountain View 18
Turku 18
Lanzhou 16
London 16
Can Tho 15
San Francisco 15
Taizhou 15
Toronto 15
Yubileyny 15
Norwalk 14
Verona 14
Xi'an 14
Düsseldorf 13
Orem 13
Rome 13
Thái Nguyên 13
Bengaluru 12
Haikou 12
Ningbo 12
Redwood City 12
Shenzhen 12
Washington 12
Atlanta 11
Des Moines 11
Totale 11.267
Salva come PNG Salva come JPEG
Nome #
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 941
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study. 275
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 270
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 262
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 257
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 254
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. 250
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 246
A randomised comparison between clopidogrel 150 mg daily maintenance dose versus 75 mg in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention 245
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 238
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 236
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 233
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 229
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 227
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 220
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 215
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 214
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 213
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system 211
Brachiterapia coronarica per la ristenosi intrastent a carico di biforcazioni: follow up angiografico a 9 mesi. 210
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 210
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 210
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 207
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 207
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 205
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 203
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 202
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 196
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 196
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 196
Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery 194
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 193
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 192
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 191
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 190
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged ³ 75 years) 189
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 189
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 188
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 185
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 184
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 184
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 184
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 182
Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis. 180
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 180
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 177
Effective and equivalent organ doses in patients undergoing coronary angiography and percutaneous coronary interventions 177
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 176
One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study 176
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 176
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 175
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 175
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 171
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 169
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 168
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 168
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 168
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 167
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 167
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 167
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 164
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 161
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 160
Prognostic significance of mean platelet volume on admission in unselected cohort of patients with non ST-segment elevation acute coronary syndrome 158
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 157
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 157
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 157
Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study 155
The safety of drug-eluting stents. 153
Risk of stroke in patients with high on clopidrogel platelet reactivity to ADP after percutaneous coronary intervention: systematic review and meta-analysis 153
Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. 152
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 152
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 151
Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. 146
Ruolo del fattore tissutale circolante nel determinare la trombosi di stent in un sistema di perfusione in vitro. 146
Predictors of complicated athero-thrombotic lesions and their prognostic significance in unselected patients with non ST-segment acute coronary syndrome 146
Electrocardiographic pattern to enhance prediction of in-hospital cardiovascular death in patients with non ST elevation acute coronary syndrome 146
Description of an In-vitro of Stent Perfusion to Study Stent Thrombosis at Different Shear Rates 145
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 145
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery? 145
Ogni lungo viaggio inizia con un piccolo passo: Il Signor C e la cardiologia interventistica 144
Significant decrease of door-to-balloon time by direct transport from ambulance to cath lab 143
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with tirofiban or Abciximab [FATA] trial) 141
False Positive Coronary Angiography Activation in a Primary Coronary Angioplasty Network: Does Direct Ambulance-based Access Influence The Prevalence Rate? 139
In the era of the valve-in-valve: is transcatheter aortic valve implantation (TAVI) in sutureless valves feasible? 132
Coronary 32P beta Brachytherapy: our singleinstitution experience 131
Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Coronary Angioplasty and Abciximab or Tirofiban: Insights From the Facilitated Angioplasty with Tirofiban or Abciximab (FATA) Randomized Trial 129
Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction 128
Valve-in-valve technique to manage acute paraprosthetic leak after transcatheter aortic valve implantation. 119
Displacement of calcium nodules of the native valve as a possible cause of left main occlusion following transcatheter aortic valve implantation. 108
Emergency balloon aortic valvuloplasty in patients with critical aortic stenosis presenting with cardiogenic shock. 91
null 86
null 72
The conundrum of transient cortical blindness following coronary angiography. 69
Totale 17.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.434 0 0 0 173 139 109 29 100 58 151 344 331
2022/20232.280 211 324 136 279 220 154 47 148 396 54 200 111
2023/2024491 35 63 30 58 56 146 17 31 5 26 9 15
2024/20252.049 95 304 172 147 395 80 90 49 25 165 60 467
2025/20265.201 351 410 332 390 510 607 755 187 1.008 395 134 122
2026/2027668 69 149 359 91 0 0 0 0 0 0 0 0
Totale 17.541